Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

PROVIDENCE — As Vertex Pharmaceuticals Inc. looks to consolidate its properties around Rhode Island, executives told state officials they plan to slash dozens of jobs and shutter two offices.

Vertex Pharmaceuticals missed first-quarter profit and revenue forecasts as costs jumped.

Vertex Pharmaceuticals Inc (VRTX) reports a 3% revenue increase, driven by US growth and new product launches, despite international setbacks.

Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta, sending shares down 2.5% after the bell.

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue ...

Vertex Solutions Earns Contract to Provide Immersive Training to Air Force Branch to receive delivery of 25 advanced tech T-38 Gen 2 training devices.

Vertex Pharmaceuticals (Nasdaq: VRTX) specialises in treatments for rare diseases. It has eight approved medicines on the market. Seven of these are medicines for various types of cystic fibrosis ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).

Vertex Pharmaceuticals’ Jounavx is now FDA approved, providing patients a non-opioid option for treating acute pain. The twice-daily pill is the first in a new class of medicines that block a ...

Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout Analysts and pain experts have characterized the drug as modestly effective ...